Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 2

Status

Recruiting 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other 5Gynecologic 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Obesity 5Endometrial Neoplasms 4Endometrial Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Opioid-Related Disorders 1Lymphoma, Follicular 1Insulin Resistance 1Hyperplasia 1Diabetes Mellitus 1

Interventions

Tirzepatide 5Resistance Training 2Megestrol Acetate 2Counseling 2semaglutide 1mirabegron 1Weights and Measures 1Vitamin D 1Tablets 1Stents 1Spermine Synthase 1Specimen Handling 1Progestins 1Population Groups 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Methods 1Metformin 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hysteroscopy 1Hydroquinones 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1Diet Therapy 1Communication Devices for People with Disabilities 1Cholecalciferol 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Obesity × Tirzepatide × 90 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07228741 2026-06-04

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital

Phase 2 Recruiting
20 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06485089 2026-05-28

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

University of Kansas Medical Center

Completed
25 enrolled
Other

Obesity

NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT06751589 2026-04-13

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
36 enrolled
GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡